Observational Study of Patient Reported Outcomes Following Percutaneous Lung Ablation

This study is looking at how people with lung tumors feel before and after a procedure called percutaneous lung ablation. This procedure uses heat or cold to destroy small tumors. Researchers want to understand your satisfaction with the treatment and any symptoms you experience. You can join if you are 18 or older and are scheduled to have percutaneous lung ablation. The study will measure your symptom severity at different times: before the procedure, and then 1 day, 3 days, 7 days, 1 month, and 3 months afterward. This is an observational study, meaning researchers will collect information without giving you any new treatments.

Study design
This is an observational study involving about 50 participants. It is not testing a new treatment, but rather observing experiences with an existing procedure.
What's involved
You would share information about your symptoms and satisfaction at different times: before your ablation, and then 1 day, 3 days, 7 days, 1 month, and 3 months after the procedure.
Compensation
Not stated in the trial record.
Follow-up
Your symptoms will be followed for up to 3 months after your percutaneous lung ablation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07720102

Patient Reported Outcomes Following Percutaneous Lung Ablation

Not Yet Recruiting
Not specifiedAges 18+Observational
Mayo Clinic
~50 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Non-Interventional Study

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Symptom severity following percutaneous lung ablation
Measured over Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months
Lung Neoplasm
1 sites across 1 states
Minnesota1
  • Ahmad Parvinian, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic in Rochester

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Undergoing percutaneous lung ablation

Exclusion

Decline to participate in research
  • Symptom severity following percutaneous lung ablationBaseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months

    Assessed using a study-specific survey. Participants evaluate 5 symptoms (pain, fatigue, drowsiness, shortness of breath, and disturbed sleep), each on an 11-point Likert scale of 0-10 where 0=absence of symptoms and 10=as bas as you can imagine. Higher scores indicate greater severity of symptoms.